IZILOX 400 mg, film-coated tablet 7 tablets
Active ingredients: Moxifloxacin hydrochloride, Moxifloxacin
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet7 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IZILOX 400 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 7 comprimé(s)
- Marketing authorisation holder
- BAYER HEALTHCARE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 20 Mar 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69531658CIP73015910CIP133400930159101Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MOXIFLOXACINEcomprimé | 400 mg · un comprimé | FT |
| CHLORHYDRATE DE MOXIFLOXACINEcomprimé | 436,8 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.